Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (32,901)	$ (79,336)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	842	1,418
Share-based compensation	9,933	12,856
Credit loss expense	1,020	3,014
Common stock warrant liability adjustment	924	(6,337)
Amortization of right of use assets	1,369	1,253
Other adjustments, net	109	953
Changes in assets and liabilities:
Accounts receivable	965	(8,504)
Prepaid expenses and other assets	3,177	6,226
Inventory	12,118	(1,181)
Accounts payable and accrued and other expenses	(19,503)	(10,720)
Other, net	(1,580)	(1,022)
Net cash used in operating activities	(23,527)	(81,380)
Cash flows from investing activities
Purchase of property and equipment	(16)	(636)
Purchase of intangible assets	(43)	(929)
Net cash used in investing activities	(59)	(1,565)
Cash flows from financing activities
Proceeds from issuance of preferred stock, net of $1,513 of paid transaction costs	28,487	0
Proceeds from short-term borrowings	99,988	44,530
Payments of short-term borrowings	(96,832)	(40,026)
Proceeds from long-term borrowings	500	0
Payments of long-term borrowings	(3,500)	(6,000)
Other, net	269	618
Net cash provided by (used in) financing activities	28,912	(878)
Net change in cash and cash equivalents	5,326	(83,823)
Cash and cash equivalents at beginning of period	11,231	95,054
Cash and cash equivalents at end of period	16,557	11,231
Supplemental disclosure of cash flow information:
Cash paid for interest	1,876	1,075
Supplemental disclosure of non-cash financing activities:
Conversion of convertible preferred stock to common stock	$ 350	$ 0